Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Policy / Pricing
  • RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders
  • Policy / Pricing

RFK Jr. rewrites ACIP rules; Gilead, Roche dig into protein degraders

BioPharma Dive

The newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety.

Policy / PricingRead full story

pharminent April 10, 2026 (Last updated: April 10, 2026)

BioPharma Dive

The newly published charter widens the required expertise to become an ACIP member and stresses vaccine safety.

Policy / PricingRead full story

Post navigation

Previous: With oral obesity race underway, all eyes are on Lilly’s Foundayo launch
Next: Oricell closes a ‘pre-IPO’ megaround to aim CAR-T at solid tumors

Related Stories

  • Policy / Pricing

Mid-cap biotechs join Trump’s latest round of drug pricing deals

pharminent September 1, 2026
  • Policy / Pricing

MFN sparks defiance from Europe’s larger nations, uncertainty among smaller ones

pharminent August 27, 2026
  • Policy / Pricing

MFN affecting Swiss medicines access, says Interpharma

pharminent August 13, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.